Edition:
United States

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

4.33USD
19 Jul 2018
Change (% chg)

$-0.04 (-0.92%)
Prev Close
$4.37
Open
$4.35
Day's High
$4.42
Day's Low
$4.27
Volume
38,286
Avg. Vol
144,209
52-wk High
$7.94
52-wk Low
$3.23

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 December 20 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 10.80 13.00 8.69 7.00
Quarter Ending Dec-18 6 10.54 16.00 6.24 0.21
Year Ending Dec-18 6 40.28 47.70 34.25 25.75
Year Ending Dec-19 5 55.84 85.00 34.00 73.78
Earnings (per share)
Quarter Ending Sep-18 6 -0.14 -0.08 -0.24 -0.21
Quarter Ending Dec-18 6 -0.19 -0.06 -0.33 -0.42
Year Ending Dec-18 6 -0.68 -0.33 -0.95 -0.09
Year Ending Dec-19 5 -0.07 0.64 -0.98 0.88

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 8.88 9.74 0.86 9.70
Quarter Ending Dec-17 9.66 8.80 0.86 8.86
Quarter Ending Sep-17 16.06 9.56 6.50 40.46
Quarter Ending Jun-17 7.75 10.01 2.26 29.16
Quarter Ending Mar-17 5.31 7.00 1.68 31.70
Earnings (per share)
Quarter Ending Mar-18 -0.17 -0.17 0.00 -1.90
Quarter Ending Dec-17 -0.17 -0.15 0.02 -10.87
Quarter Ending Sep-17 -0.05 -0.13 0.08 -178.37
Quarter Ending Jun-17 -0.17 -0.19 0.02 -15.15
Quarter Ending Mar-17 -0.22 -0.14 0.08 -35.96

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 10.80 10.80 10.80 10.80 7.00
Quarter Ending Dec-18 10.54 10.54 10.54 10.54 0.21
Year Ending Dec-18 40.28 40.28 40.28 40.28 25.75
Year Ending Dec-19 55.84 55.84 55.84 55.84 73.78
Earnings (per share)
Quarter Ending Sep-18 -0.14 -0.14 -0.14 -0.14 -0.21
Quarter Ending Dec-18 -0.19 -0.19 -0.19 -0.19 -0.42
Year Ending Dec-18 -0.68 -0.68 -0.68 -0.68 -0.09
Year Ending Dec-19 -0.07 -0.07 -0.07 -0.07 0.88

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0